Lucknow, India

Anju Puri

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anju Puri. Retrieved from https://idiyas.com/inventor/anju-puri-j0cbdflj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anju Puri: Innovator in Antidiabetic Research

Introduction

Anju Puri is a notable inventor based in Lucknow, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antidiabetic properties. Her work focuses on creating innovative solutions to combat diabetes, a growing health concern worldwide.

Latest Patents

Anju Puri holds a patent for "Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents." This invention provides appropriately substituted chalcones, which are represented by a specific structural formula. The compounds exhibit significant antidiabetic effects in various animal models, indicating their potential for further exploitation in medical applications. She has 1 patent to her name.

Career Highlights

Throughout her career, Anju Puri has demonstrated a commitment to advancing research in the field of diabetes treatment. Her innovative approach to developing new compounds has garnered attention and respect within the scientific community.

Collaborations

Anju has collaborated with notable colleagues, including Ram Pratap and Mavurapu Satyanarayana. These partnerships have contributed to her research and the successful development of her patented compounds.

Conclusion

Anju Puri's work in the field of antidiabetic research showcases her dedication to innovation and improving health outcomes. Her contributions are paving the way for future advancements in diabetes treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…